INTEGRA LIFESCIENCES HOLDINGS CORP Revenues
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Revenues of $357.08 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-04-26.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2018-04-26
- INTEGRA LIFESCIENCES HOLDINGS CORP revenues for the quarter ending 2018-03-31 was $357.08M, a 38.06% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP revenues for the quarter ending 2017-09-30 was $278.83M, a 11.39% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP revenues for the quarter ending 2017-06-30 was $282.16M, a 13.18% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP revenues for the quarter ending 2017-03-31 was $258.64M, a 9.24% increase year-over-year.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 9 month as first filed |
|---|---|---|---|---|---|---|
| 2018-03-31 | $357.08M 10-Q · filed 2018-04-26 | |||||
| 2017-09-30 | $278.83M 10-Q · filed 2017-10-26 | $561.00M derived: sum of 2 quarters · filed 2017-10-26 | $819.63M 10-Q · filed 2017-10-26 | |||
| 2017-06-30 | $282.16M 10-Q · filed 2017-07-26 | $540.80M 10-Q · filed 2017-07-26 | ||||
| 2017-03-31 | $258.64M 10-Q · filed 2018-04-26 | |||||
| 2016-09-30 | $250.33M 10-Q · filed 2017-10-26 | $499.64M derived: sum of 2 quarters · filed 2017-10-26 | $736.41M 10-Q · filed 2017-10-26 | |||
| 2016-06-30 | $249.31M 10-Q · filed 2017-07-26 | $486.08M 10-Q · filed 2017-07-26 | ||||
| 2016-03-31 | $236.77M 10-Q · filed 2017-04-26 | |||||
| 2015-09-30 | $226.37M 10-Q · filed 2016-10-28 | $439.04M derived: sum of 2 quarters · filed 2016-10-28 | $641.57M 10-Q · filed 2016-10-28 | |||
| 2015-06-30 | $212.67M 10-Q · filed 2016-07-28 | $244.08M 10-Q · filed 2015-07-31 | $415.21M 10-Q · filed 2016-07-28 | $477.74M 10-Q · filed 2015-07-31 | ||
| 2015-03-31 | $202.53M 10-Q · filed 2016-04-27 | $233.66M 10-Q · filed 2015-05-01 | ||||
| 2014-09-30 | $197.52M 10-Q · filed 2015-11-04 | $229.72M 10-Q · filed 2014-11-07 | $428.87M derived: sum of 2 quarters · filed 2015-11-04 | $577.64M 10-Q · filed 2015-11-04 | $676.13M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $231.35M 10-Q · filed 2015-07-31 | $446.41M 10-Q · filed 2015-07-31 | ||||
| 2014-03-31 | $215.06M 10-Q · filed 2015-05-01 | |||||
| 2013-09-30 | $213.25M 10-Q · filed 2014-11-07 | $418.79M derived: sum of 2 quarters · filed 2014-11-07 | $615.45M 10-Q · filed 2014-11-07 | |||
| 2013-06-30 | $205.55M 10-Q · filed 2014-08-05 | $402.20M 10-Q · filed 2014-08-05 | ||||
| 2013-03-31 | $196.65M 10-Q · filed 2014-05-01 | |||||
| 2012-09-30 | $210.08M 10-Q · filed 2013-10-30 | $616.44M 10-Q · filed 2013-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |